Sjögren's disease & overlap diseases

A Scoping Review and Meta‐Analysis of Proportions of Central Nervous System Manifestations Reported in Patients with Sjögren's Disease

Arthritis Care Res (Hoboken)Published Scoping review and meta-analysis of proportions

Authors' conclusion

The spectrum of CNS involvement in Sjögren's disease is broad and heterogeneous.

Study context

Population
Individuals living with SjD; MEDLINE, Embase (1980–January 29, 2026) and ECRI Guidelines Trust (2020–January 29, 2026)108 studies
Outcome
Proportion of individuals with SjD who experience CNS manifestations
Methodological detailsduplicate screening, prespecified inclusion and exclusion criteria, a priori sensitivity analyses for statistical outliers
  • Duplicate screening
  • Prespecified inclusion and exclusion criteria
  • A priori sensitivity analyses for statistical outliers

Pooled result

As reported in the abstract

Pooled proportions of CNS manifestations
  • Pooled proportion estimates generated for 23 central nervous system (CNS) manifestations
  • Frequencies exceeding those in the general population: depression, migraine, insomnia, cognitive dysfunction, psychosis, movement disorders, aseptic meningoencephalitis, neuromyelitis optica spectrum disorder, optic neuritis, multiple sclerosis, cerebral vasculitis, cerebellar syndrome, spinal cord involvement, non-localizing somatosensory complaints
  • Degree of increased frequency differed substantially across manifestations; several estimates highly influenced by individual studies (sensitivity analyses)

Original publication

A Scoping Review and Meta‐Analysis of Proportions of Central Nervous System Manifestations Reported in Patients with Sjögren's Disease. Arthritis Care Res (Hoboken). Published 21 September 2026. doi:10.1002/acr.80166

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.